Literature DB >> 4019947

National Institutes of Health workshop summary. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in individuals with asthma.

.   

Abstract

The participants in the workshop reached unanimous consensus that, as an investigative tool, BAL has enormous potential for extending knowledge of the immunopathogenesis of asthma. When BAL is used according to these guidelines, maximum knowledge may be gained with minimal risks to study subjects. However, we wish to emphasize that the extent to which the safety of the procedure applies to those subjects with asthma and more symptoms and an FEV1 of less than 60% of predicted value remains to be established by carefully controlled clinical investigations.

Entities:  

Mesh:

Year:  1985        PMID: 4019947     DOI: 10.1016/0091-6749(85)90692-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Safety of investigative bronchoscopy in the Severe Asthma Research Program.

Authors:  Wendy C Moore; Michael D Evans; Eugene R Bleecker; William W Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Serpil C Erzurum; Douglas Curran-Everett; Raed A Dweik; Benjamin Gaston; Mark Hew; Elliot Israel; Martin L Mayse; Rodolfo M Pascual; Stephen P Peters; Lori Silveira; Sally E Wenzel; Nizar N Jarjour
Journal:  J Allergy Clin Immunol       Date:  2011-04-15       Impact factor: 10.793

2.  Epithelial ciliated beating cells essential for ex vivo ALI culture growth.

Authors:  Delphine Gras; Aurélie Petit; Jérémy Charriot; Lucie Knabe; Khuder Alagha; Anne Sophie Gamez; Céline Garulli; Arnaud Bourdin; Pascal Chanez; Nicolas Molinari; Isabelle Vachier
Journal:  BMC Pulm Med       Date:  2017-05-03       Impact factor: 3.317

3.  Safety of and cellular response to segmental bronchoprovocation in allergic asthma.

Authors:  Loren C Denlinger; Elizabeth A B Kelly; Ann M Dodge; John G McCartney; Keith C Meyer; Richard D Cornwell; Mary Jo Jackson; Michael D Evans; Nizar N Jarjour
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.